Bladder Cancer in the Elderly: Balancing Disease and Surgical Risk

Share this article:
Bladder Cancer in the Elderly: Balancing Disease and Surgical Risk
Bladder Cancer in the Elderly: Balancing Disease and Surgical Risk

Program Description

Of all the newly diagnosed bladder cancer patients, 25%-30% of them will have muscle-invasive disease that ideally will require major surgery in the form of a radical cystectomy, bilateral pelvic lymphadenectomy and creation of a urinary diversion as an integral part of curative therapy. Although an invasive extirpative and reconstructive surgery, radical cystectomy is an effective therapy to treat bladder cancer, but it is associated with significant postoperative morbidity and mortality. Recent attention has been paid not only to standardizing, but also fully compiling the true perioperative risk associated with radical cystectomy and urinary diversion.

Intended Audience

This activity has been designed to meet the needs of urologists and supporting clinicians who treat patients with bladder cancer.


Participants can earn 1 credit. The activity expires Nov. 4, 2014. 

Faculty
Daniel J. Canter, MD
Vice Chairman
Urologic Institute of Southeastern Pennsylvania
Department of Urology
Einstein Healthcare Network
Philadelphia, Pennsylvania


Educational Objectives

After completing the activity, the participant should be better able to:

  • Evaluate preoperative mechanisms for assessing surgical risk in patients with muscle-invasive bladder cancer
  • Examine existing objective criteria for making treatment decisions in this patient population
  • Relate the question of surgical frailty to stratify risk in patients with muscle-invasive bladder cancer

To take this course, go to mycme.com. The log-in information for myCME is the same as McKnight's. Please note that you will need to complete additional registration information. 

Share this article:
close

Next Article in CME/CE

Don't miss any McKnight's news

More in CME/CE

Updates on the Diagnosis and Management of Alzheimer's Disease: Screening, Imaging, and Emerging Treatment Strategies

Updates on the Diagnosis and Management of Alzheimer's ...

Alzheimer's disease is the most common form of dementia, affecting approximately 6% to 7% of the population over 65 years of age. The multifactorial etiology of Alzheimer's disease involves complex ...

Resetting the Master Body Clock: Treatment Innovations in Non-24-Hour Disorder

Resetting the Master Body Clock: Treatment Innovations in ...

This accredited activity will focus on providing an increased awareness of Non-24-Hour Disorder, and consensus recommendations for diagnosis and treatment. Two leading experts in circadian rhythm disorders will review the ...

Advances in Alzheimer's Disease

Advances in Alzheimer's Disease

This is a 30-minute webcast. This review highlights the presence of critical gaps in current knowledge about Alzheimer's disease and the progression of cognitive impairment.